Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults

10.1186/s12981-020-00272-5

Saved in:

Bibliographic Details
Main Authors:	Ho, S., Wong, J.G., Ng, O.T., Lee, C.C., Leo, Y.S., Lye, D.C.B., Wong, C.S.
Other Authors:	MEDICINE
Format:	Article
Published:	BioMed Central Ltd. 2021
Subjects:	Abacavir Antiretroviral HIV Rilpivirine Treatment-naïve
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/196593
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-196593
record_format	dspace
spelling	sg-nus-scholar.10635-1965932024-04-24T05:47:01Z Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults Ho, S. Wong, J.G. Ng, O.T. Lee, C.C. Leo, Y.S. Lye, D.C.B. Wong, C.S. MEDICINE SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Abacavir Antiretroviral HIV Rilpivirine Treatment-naïve 10.1186/s12981-020-00272-5 AIDS Research and Therapy 17 1 23 2021-08-11T06:28:25Z 2021-08-11T06:28:25Z 2020 Article Ho, S., Wong, J.G., Ng, O.T., Lee, C.C., Leo, Y.S., Lye, D.C.B., Wong, C.S. (2020). Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults. AIDS Research and Therapy 17 (1) : 23. ScholarBank@NUS Repository. https://doi.org/10.1186/s12981-020-00272-5 17426405 https://scholarbank.nus.edu.sg/handle/10635/196593 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ BioMed Central Ltd. Scopus OA2020
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Abacavir Antiretroviral HIV Rilpivirine Treatment-naïve
spellingShingle	Abacavir Antiretroviral HIV Rilpivirine Treatment-naïve Ho, S. Wong, J.G. Ng, O.T. Lee, C.C. Leo, Y.S. Lye, D.C.B. Wong, C.S. Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
description	10.1186/s12981-020-00272-5
author2	MEDICINE
author_facet	MEDICINE Ho, S. Wong, J.G. Ng, O.T. Lee, C.C. Leo, Y.S. Lye, D.C.B. Wong, C.S.
format	Article
author	Ho, S. Wong, J.G. Ng, O.T. Lee, C.C. Leo, Y.S. Lye, D.C.B. Wong, C.S.
author_sort	Ho, S.
title	Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
title_short	Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
title_full	Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
title_fullStr	Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
title_full_unstemmed	Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
title_sort	efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve hiv-1 infected adults
publisher	BioMed Central Ltd.
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/196593
_version_	1800914890625384448

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults

Similar Items